Summary
Medline Inc. (MDLN) has filed an 8-K report on August 5, 2026, primarily to announce its financial results for the second quarter and the first six months ended June 27, 2026. The company issued an earnings press release, which is attached as Exhibit 99.1 to this filing, detailing its performance during the specified periods. Investors should note that the information furnished under Item 2.02 is not considered "filed" for regulatory purposes, meaning it does not carry the same legal implications as formally filed documents, unless specifically incorporated by reference into other SEC filings.
Key Highlights
- 1Medline Inc. announced financial results for Q2 and the first six months of 2026 via an earnings press release dated August 5, 2026.
- 2The filing includes the earnings press release as Exhibit 99.1.
- 3The report pertains to the fiscal periods ending June 27, 2026.
- 4This 8-K filing is primarily informational, releasing key financial performance data.
- 5Information provided under Item 2.02 is furnished, not filed, for purposes of Section 18 of the Exchange Act.
- 6The company has also provided an Inline XBRL formatted cover page for the report.
Frequently Asked Questions
The primary purpose of this 8-K filing is to publicly disseminate Medline Inc.'s financial results for the second quarter and the first six months of 2026, as announced in their earnings press release dated August 5, 2026.
The detailed financial results are contained within the earnings press release, which is attached as Exhibit 99.1 to this Form 8-K filing.
No, the information furnished under Item 2.02 of this 8-K, including the press release, is generally considered 'furnished,' not 'filed.' This means it is not subject to the liabilities associated with Section 18 of the Exchange Act, unless Medline Inc. specifically incorporates it into another filing.
The results announced cover the second quarter and the first six months of the fiscal year, both ending on June 27, 2026.